Related Experiment Videos
[Pseudomonas pneumonia--an important differential pulmonary infiltration diagnosis in AIDS]
P Kaufmann1, M Opravil, M Hauser
1Department Innere Medizin, Universitätsspital Zürich.
Abstract:
Bacterial pneumonias are the most common pulmonary complication in HIV-infected patients. Up to now, H. influenzae and S. pneumoniae have been described as the most important germs. Within a period of 4 years we diagnosed 15 cases of pneumonia caused by P. aeruginosa. All patients were in HIV stage C3; 3F, 12M; median age 34 (24-54) years; median CD4 count 10 (0-130) microliters. Except for 3 nosocomial pneumonias, all others were community-acquired. Only 3 patients had neutropenia < 1000/microliter; 7 were intravenous drug abusers. Morphologically there were 6 cases of abscess pneumonia, in 3 of which pleural drainage was necessary because of pyopneumothorax. 4 patients showed bilateral infiltrates that could not be differentiated from those of P. carinii pneumonia. Our diagnosis was based on quantitative cultures of broncho-alveolar lavage fluid (9 cases, two of them with concurrent positive blood cultures/positive cultures of the pleural fluid), pleural puncture (one case), sputum in pneumonias responding only to antipseudomonas therapy (3 cases), and autopsy (2 cases). 8 patients died of pseudomonas pneumonia within 1-3 months despite therapy. 7 patients received pseudomonas-specific combination therapy, but all died after median 9 (4-15) months of the underlying illness. In 3 cases recurrent pseudomonas pneumonia could be documented bacteriologically. We conclude that in HIV-infected patients pneumonia caused by P. aeruginosa is a significant and severe pulmonary complication.
Insights
Pseudomonas aeruginosa pneumonia is a severe complication in advanced HIV patients. This study found it often presents as community-acquired pneumonia and is frequently fatal, even with specific treatment.
Area of Science:
- Infectious Diseases
- Pulmonology
- HIV/AIDS Medicine
Background:
- Bacterial pneumonias are common in HIV-infected individuals, with Haemophilus influenzae and Streptococcus pneumoniae traditionally identified as primary pathogens.
- This study investigates the role of Pseudomonas aeruginosa as a cause of pneumonia in human immunodeficiency virus (HIV)-infected patients, particularly those in advanced stages of the disease.
Observation:
- Fifteen cases of Pseudomonas aeruginosa pneumonia were diagnosed in HIV-infected patients (stage C3), with a median age of 34 years and a median CD4 count of 10 cells/microliter.
- Most cases were community-acquired, with some presenting as abscess pneumonia or bilateral infiltrates mimicking Pneumocystis pneumonia.
- Risk factors included intravenous drug use in some patients; neutropenia was uncommon.
Findings:
- Pseudomonas aeruginosa pneumonia was associated with high mortality, with 8 patients dying within 1-3 months despite therapy.
- Even with pseudomonas-specific combination therapy, all treated patients died within a median of 9 months from their underlying illness.
- Recurrent Pseudomonas aeruginosa pneumonia was observed in 3 cases.
Implications:
- Pseudomonas aeruginosa represents a significant and severe pulmonary threat in advanced HIV infection, challenging standard treatment approaches.
- The findings underscore the need for increased awareness and potentially novel therapeutic strategies for Pseudomonas aeruginosa pneumonia in immunocompromised populations.
- Early and accurate diagnosis, possibly through quantitative cultures, is crucial for managing this severe complication.